CRLF2 and acute lymphoblastic leukemia: More than half of the cases of Ph-like ALL show an overexpression of CRLF2, whereby almost half of the cases show a JAK-STAT mutation (often JAK2-R683G) and a concomitant activation of the JAK-STAT signaling pathway [189].